Updated on 6 March 2013
Bangalore: Agila Specialties, a wholly owned subsidiary of Strides Arcolab, has received ANDA approval for Zoledronic Acid Injection 4 mg (base) / 5 mL, packaged in single dose vials.
According to IMS data, the US market for Zoledronic Acid 5ML s approximately $520 Million. The product is expected to be launched shortly.
Zoledronic Acid is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones.
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
